These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7492839)

  • 1. [Guidelines from the National Federation of Cancer Prevention Centers (FNCLOC) on trials of drug prevention of breast cancer by tamoxifen ].
    Eisinger F; Laffargue F; Maraninchi D; Mauvais-Jarvis P; Moatti JP; Namer M; Pujol H; Philip T; Sancho-Garnier H
    Bull Cancer; 1995 Jul; 82 Suppl 3():237s-238s. PubMed ID: 7492839
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen for the prevention of breast cancer: no.
    DeGregorio MW; Maenpaa JU; Wiebe VJ
    Important Adv Oncol; 1995; ():175-85. PubMed ID: 7672804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of breast cancer with tamoxifen in women at increased risk.
    Vogel VG
    J Clin Oncol; 2001 Sep; 19(18 Suppl):87S-92S. PubMed ID: 11560980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology].
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):727-8. PubMed ID: 7995922
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    Fabian CJ; Kimler BF
    J Clin Oncol; 2005 Mar; 23(8):1644-55. PubMed ID: 15755972
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF; Eppes PG; Wilson CT
    Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors and the prevention of breast cancer with tamoxifen.
    Morrow M; Jordan VC
    Cancer Surv; 1993; 18():211-29. PubMed ID: 8012998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian suppression for breast cancer: an effective treatment in search of a home.
    Krop IE; Winer EP
    J Clin Oncol; 2005 Sep; 23(25):5869-72. PubMed ID: 16087947
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
    Vogel VG
    Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial.
    Giles K; Flynn PJ; Dalton R; Zera R
    Minn Med; 1993 Dec; 76(12):25-7. PubMed ID: 8127293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Prevention Trial update.
    Facundus M; Lifsey D; Kardinal CG
    J La State Med Soc; 1993 Apr; 145(4):147-9. PubMed ID: 8486986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
    Reichert D; Illiger HJ
    Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.